Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022.

Saved in:
Bibliographic Details
Title: Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022.
Authors: O'Laughlin K, Tobolowsky FA, Elmor R, Overton R, O'Connor SM, Damon IK, Petersen BW, Rao AK, Chatham-Stephens K, Yu P, Yu Y
Corporate Authors: CDC Monkeypox Tecovirimat Data Abstraction Team
Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Sep 16; Vol. 71 (37), pp. 1190-1195. Date of Electronic Publication: 2022 Sep 16.
Publication Type: Journal Article
Journal Info: Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1545-861X
DOI:10.15585/mmwr.mm7137e1